Hematopoietic stem cell transplantation for patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a retrospective study of 21 patients from SFGM-TC centers.
Fiche publication
Date publication
mars 2018
Journal
Haematologica
Auteurs
Membres identifiés du Cancéropôle Est :
Pr RUBIO Marie Thérèse
Tous les auteurs :
Vallet N, de Fontbrune FS, Loschi M, Desmier D, Villate A, Barraco F, Chevallier P, Terriou L, Yakoub-Agha I, Ruggeri A, Mohty M, Maillard N, Rohrlich PS, Ceballos P, Nguyen S, Poiré X, Guillerm G, Tabrizi R, Farhi J, Devillier R, Rubio MT, Socié G, de Latour RP,
Lien Pubmed
Mots clés
Adult, Aged, Antibodies, Monoclonal, Humanized, therapeutic use, Hematopoietic Stem Cell Transplantation, adverse effects, Hemoglobinuria, Paroxysmal, complications, Humans, Middle Aged, Registries, Retrospective Studies, Young Adult
Référence
Haematologica. 2018 Mar;103(3):e103-e105